Doctrine of Equivalents in Patent Prosecution: DOE Application, Festo Exceptions, Recent Case Law Developments
A live 90-minute premium CLE video webinar with interactive Q&A
This CLE course will guide patent counsel on the doctrine of equivalents (DOE). The panel will discuss Federal Circuit DOE decisions applying the Festo exceptions. The panel will also discuss the implications of the Supreme Court's decision to decline review of NexStep Inc. v. Comcast Cable Communications. Other recent Federal Circuit decisions on judicial exceptions to DOE will also be analyzed.
Outline
- Early DOE decisions; policy considerations
- Estoppel
- Argument-based
- Amendment-based
- Festo
- Exceptions
- The equivalent was unforeseeable at the time of the application
- Tangential relation
- An unreasonable expectation to describe the insubstantial substitute
- Exceptions
- Hypothetical claims/ensnarement
- Disclosure-dedication
- All-limitations rule
Benefits
The panel will review these and other important issues:
- The reappearance of the Festo exceptions
- The return of ensnarement
- Best practices for drafting and prosecuting claims to minimize estoppel-preventing DOE arguments
Faculty

Dr. Paul W. Browning, Ph.D.
Partner
Finnegan Henderson Farabow Garrett & Dunner
Dr. Browning, Ph.D., is a first chair litigator focusing on patent litigation and appeals, primarily in the chemical... | Read More
Dr. Browning, Ph.D., is a first chair litigator focusing on patent litigation and appeals, primarily in the chemical and pharmaceutical areas, including Hatch-Waxman litigation. He has tried cases before judges in various U.S. district courts and has handled arbitrations and mediations. Dr. Browning also advises on patent portfolio strategy with an eye toward success in litigation. His broad litigation experience includes taking and cross-examining witnesses at trial, briefing and arguing dispositive motions, drafting appellate briefs, and arguing cases on appeal. Dr. Browning has also managed day-to-day litigation activities in actions involving multiple parties. In addition to his litigation practice, he advises clients on a variety of patent matters, including strategic development of their patent portfolios and coordination of prosecution and U.S. and foreign litigation strategy and related proceedings before the Patent Trial and Appeal Board (PTAB). Dr. Browning has been recognized as a litigation star by Benchmark Litigation and Managing Intellectual Property (MIP) named him as a notable practitioner in the District of Columbia. He frequently lectures on various topics in chemical patent law. Dr. Browning designed laser systems and conducted spectroscopy of small molecules while earning master’s and Ph.D. degrees at the University of Chicago.
Close
Thomas L. Irving
Partner
The Marbury Law Group
Mr. Irving has 47 years of experience in the field of IP law. His practice includes due diligence, patent prosecution,... | Read More
Mr. Irving has 47 years of experience in the field of IP law. His practice includes due diligence, patent prosecution, reissue and reexamination, patent interferences, and counseling, including prelitigation, Orange Book listings of patents covering FDA-approved drugs, and infringement and validity analysis in the chemical fields, as well as litigation. He has served as lead counsel in many patent interferences.
Close
Dr. Amanda K. Murphy, Ph.D.
Partner
Finnegan Henderson Farabow Garrett & Dunner
Dr. Murphy focuses her practice on client counseling and patent prosecution for a range of clients. She prepares new... | Read More
Dr. Murphy focuses her practice on client counseling and patent prosecution for a range of clients. She prepares new patent applications, prosecutes U.S. and foreign applications, and represents applicants at appeals and oral hearings before the PTAB. She has experience in prosecuting inter partes and ex partes reexamination applications, reissue applications, and patent term extension applications for approved pharmaceuticals, including obtaining supplemental protection certificates in Europe.
Close
Michelle E. O'Brien
Partner, Head of Life Sciences
The Marbury Law Group
Ms. O’Brien has more than 20 years of experience representing domestic and foreign clients of all sizes in... | Read More
Ms. O’Brien has more than 20 years of experience representing domestic and foreign clients of all sizes in patent procurement, litigation, and client counseling, with a particular emphasis on chemical, biochemical, and pharmaceutical technologies. Exemplary areas of her technical expertise include polymer chemistry; ceramics; glass; food chemistry; cosmetics; paper products; adhesives; and pharmaceutical products, including new chemical entities and formulations and novel solid forms, including polymorphs, cocrystals, and amorphous forms of compounds.
CloseEarly Discount (through 09/26/25)